CA2215382A1 - Injection mensuelle utile comme contraceptif a effet retard et pourl'ho rmonotherapie substitutive chez les femmes perimenopausiques et premenopausiques - Google Patents
Injection mensuelle utile comme contraceptif a effet retard et pourl'ho rmonotherapie substitutive chez les femmes perimenopausiques et premenopausiques Download PDFInfo
- Publication number
- CA2215382A1 CA2215382A1 CA002215382A CA2215382A CA2215382A1 CA 2215382 A1 CA2215382 A1 CA 2215382A1 CA 002215382 A CA002215382 A CA 002215382A CA 2215382 A CA2215382 A CA 2215382A CA 2215382 A1 CA2215382 A1 CA 2215382A1
- Authority
- CA
- Canada
- Prior art keywords
- estradiol
- once
- month
- perimenopausal
- acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne l'utilisation d'une injection mensuelle qui contient des composants oestrogènes et gestagènes comme principes actifs pour préparer un médicament contraceptif utile en même temps en hormonothérapie substitutive pour femmes dans la périménopause et dans la préménopause. On obtient avec ce médicament un effet contraceptif fiable avec un oestrogène "naturel" (sans éthinyloestradiol), ainsi qu'une thérapie efficace des premiers symptômes d'insuffisance d'oestrogène, ainsi qu'une prophylaxie de l'ostéoporose.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19510861.2 | 1995-03-16 | ||
DE19510861A DE19510861A1 (de) | 1995-03-16 | 1995-03-16 | Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2215382A1 true CA2215382A1 (fr) | 1996-09-19 |
Family
ID=7757668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002215382A Abandoned CA2215382A1 (fr) | 1995-03-16 | 1996-03-15 | Injection mensuelle utile comme contraceptif a effet retard et pourl'ho rmonotherapie substitutive chez les femmes perimenopausiques et premenopausiques |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0814811A1 (fr) |
JP (1) | JPH11501649A (fr) |
KR (1) | KR19980703058A (fr) |
AR (1) | AR002283A1 (fr) |
AU (1) | AU713258B2 (fr) |
CA (1) | CA2215382A1 (fr) |
CZ (1) | CZ289697A3 (fr) |
DE (1) | DE19510861A1 (fr) |
HU (1) | HUP9801691A3 (fr) |
IL (1) | IL117516A (fr) |
MX (1) | MX9707009A (fr) |
NO (1) | NO974255L (fr) |
NZ (1) | NZ304027A (fr) |
PL (1) | PL322202A1 (fr) |
SK (1) | SK123997A3 (fr) |
WO (1) | WO1996028165A1 (fr) |
ZA (1) | ZA962177B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
-
1995
- 1995-03-16 DE DE19510861A patent/DE19510861A1/de not_active Withdrawn
-
1996
- 1996-03-15 JP JP8527295A patent/JPH11501649A/ja not_active Ceased
- 1996-03-15 AR ARP960101766A patent/AR002283A1/es unknown
- 1996-03-15 AU AU51108/96A patent/AU713258B2/en not_active Ceased
- 1996-03-15 PL PL96322202A patent/PL322202A1/xx unknown
- 1996-03-15 KR KR1019970706467A patent/KR19980703058A/ko not_active Application Discontinuation
- 1996-03-15 EP EP96907506A patent/EP0814811A1/fr not_active Withdrawn
- 1996-03-15 CA CA002215382A patent/CA2215382A1/fr not_active Abandoned
- 1996-03-15 HU HU9801691A patent/HUP9801691A3/hu unknown
- 1996-03-15 WO PCT/EP1996/001201 patent/WO1996028165A1/fr not_active Application Discontinuation
- 1996-03-15 CZ CZ972896A patent/CZ289697A3/cs unknown
- 1996-03-15 MX MX9707009A patent/MX9707009A/es not_active IP Right Cessation
- 1996-03-15 SK SK1239-97A patent/SK123997A3/sk unknown
- 1996-03-15 NZ NZ304027A patent/NZ304027A/xx not_active IP Right Cessation
- 1996-03-17 IL IL11751696A patent/IL117516A/xx not_active IP Right Cessation
- 1996-03-18 ZA ZA962177A patent/ZA962177B/xx unknown
-
1997
- 1997-09-15 NO NO974255A patent/NO974255L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL322202A1 (en) | 1998-01-19 |
CZ289697A3 (en) | 1997-12-17 |
KR19980703058A (ko) | 1998-09-05 |
NZ304027A (en) | 2000-05-26 |
SK123997A3 (en) | 1998-02-04 |
IL117516A (en) | 2000-07-26 |
IL117516A0 (en) | 1996-07-23 |
AR002283A1 (es) | 1998-03-11 |
HUP9801691A3 (en) | 1999-03-01 |
WO1996028165A1 (fr) | 1996-09-19 |
MX9707009A (es) | 1997-11-29 |
DE19510861A1 (de) | 1996-09-19 |
NO974255D0 (no) | 1997-09-15 |
AU713258B2 (en) | 1999-11-25 |
JPH11501649A (ja) | 1999-02-09 |
HUP9801691A2 (hu) | 1998-11-30 |
AU5110896A (en) | 1996-10-02 |
ZA962177B (en) | 1996-07-29 |
NO974255L (no) | 1997-11-14 |
EP0814811A1 (fr) | 1998-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2189819C2 (ru) | Схемы приема прогестогена-антипрогестогена | |
US20090005351A1 (en) | Hormone replacement therapy | |
FI117850B (fi) | Progesteroniantagonisteja lääkeaineiden valmistamiseksi, jotka on tarkoitettu kohdun toimintahäiriöistä johtuvien verenvuotojen hoitamiseksi | |
HU221169B1 (en) | Use of estrogen and antiprogestin for producing pharmaceutical compositions useful in hormon replacement therapy and kit containing the same | |
HU223753B1 (hu) | Természetes ösztrogén bázisú többlépcsős fogamzásgátló készítmény | |
AU2001250034A1 (en) | Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate | |
US6506390B2 (en) | Progestogen-anti-progestogen regimens | |
AU2005237255A1 (en) | Management of breakthrough bleeding in extended hormonal contraceptive regimens | |
KR970704450A (ko) | 자궁내막증식증 또는 자궁평활근종을 치료하기 위한 프로게스테론 길항제 및 게스타겐의 용도(Use of a Progesterone Antagonist and of a Gestagen for the Treatment of Endometriosis or Leiomyomate Uteri) | |
JP2000502108A (ja) | ゲストゲンとエストロゲン併用によるほ乳動物の避妊法とキット | |
JP2007511533A (ja) | 段階的エストロゲン避妊薬 | |
AU2005235418C1 (en) | Multi-phase contraceptive preparation based on a natural estrogen | |
US20090137537A1 (en) | Therapeutic gestagens for the treatment of premenstrual dysphoric disorder | |
BG62877B1 (bg) | Метод за контрол на женски фертилитет | |
US20010006963A1 (en) | Once-a-month injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women | |
AU759925B2 (en) | Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin | |
JP2942560B2 (ja) | エストロゲン欠乏症治療用組成物 | |
JP2005530791A (ja) | 結合型エストロゲンとトリメゲストンの組み合わせを用いたホルモン補充療法 | |
AU713258B2 (en) | Once-a-month-injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women | |
US20030176404A1 (en) | Progestogen-anti-progestogen regimens | |
WO2021260511A1 (fr) | Thérapie hormonale de substitution et/ou contraceptive multiphasique | |
EP1007052A1 (fr) | Associations de progestatifs conservant l'endometre et de progestatifs atrophiant l'endometre avec des oestrogenes, destinees a la contraception orale | |
JP2005530790A (ja) | 閉経後の障害を治療するためのトリメゲストンおよびエストロゲン | |
JP2005527574A (ja) | ホルモン補充療法におけるトリメゲストンと組み合わせた結合型エストロゲンの使用 | |
JP2005527577A (ja) | ホルモン補充療法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |